Compare NUVB & FDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | FDP |
|---|---|---|
| Founded | 2018 | 1886 |
| Country | United States | Cayman Islands |
| Employees | 298 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | 1999 |
| Metric | NUVB | FDP |
|---|---|---|
| Price | $4.76 | $37.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 206.0K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $4,322,300,000.00 |
| Revenue This Year | $203.82 | N/A |
| Revenue Next Year | $58.18 | $3.14 |
| P/E Ratio | ★ N/A | $179.67 |
| Revenue Growth | N/A | ★ 0.98 |
| 52 Week Low | $1.57 | $31.85 |
| 52 Week High | $9.75 | $43.58 |
| Indicator | NUVB | FDP |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 29.12 |
| Support Level | $4.06 | $34.76 |
| Resistance Level | $5.42 | $38.50 |
| Average True Range (ATR) | 0.33 | 1.23 |
| MACD | 0.01 | -0.53 |
| Stochastic Oscillator | 54.70 | 11.82 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.